Original Research
Published on 14 Jul 2022
APOBEC3 selects V179I in HIV-1 reverse transcriptase to provide selective advantage for non-nucleoside reverse transcriptase inhibitor-resistant mutants
- 2,991 views
- 3 citations
Original Research
Published on 14 Jul 2022
Original Research
Published on 14 Jul 2022
Correction
Published on 13 Jul 2022
Brief Research Report
Published on 13 Jul 2022
Original Research
Published on 08 Jul 2022
Review
Published on 07 Jul 2022
Original Research
Published on 07 Jul 2022
Review
Published on 05 Jul 2022
Original Research
Published on 04 Jul 2022
Original Research
Published on 01 Jul 2022
Original Research
Published on 30 Jun 2022
Review
Published on 29 Jun 2022
Methods
Published on 27 Jun 2022
Brief Research Report
Published on 24 Jun 2022
Original Research
Published on 17 Jun 2022
Review
Published on 16 Jun 2022
Original Research
Published on 16 Jun 2022
Brief Research Report
Published on 16 Jun 2022
Editorial
Published on 14 Jun 2022
Brief Research Report
Published on 13 Jun 2022
Original Research
Published on 10 Jun 2022
Brief Research Report
Published on 06 Jun 2022
Review
Published on 02 Jun 2022
Original Research
Published on 02 Jun 2022